CoChat

Amyloid PET in Dementia Syndromes: A Chinese Multicenter Study

Open access
Shi, Zhihong, Fu, Li-ping, Zhang, Nan, Zhao, Xiaobin, Liu, Shuai, Zuo, Chuantao, Cai, Li, Wang, Ying, Gao, Shuo, Ai, Lin, Guan, Yi-Hui, Xu, Baixuan, Ji, Yong · 2020 · Journal of Nuclear Medicine
Cited by 30

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Cerebral β-amyloid deposits and regional glucose metabolism assessed by PET are used to distinguish between Alzheimer disease (AD) and other dementia syndromes. In the present multicenter study, we estimated the prevalence of β-amyloid deposits on PET imaging in a wide variety of dementia syndromes and mild cognitive impairment (MCI) within a memory clinic population. Methods: Of the 1,193 consecutive patients with cognitive impairment (CI) who received 1 11C-PIB PET or 18F-AV45 PET or both 11C-PIB PET and 18F-AV45 PET, 960 were diagnosed with AD, 36 with frontotemporal dementia (FTD), 5 with dementia with Lewy bodies, 144 with MCI, 29 with vascular dementia, 4 with corticobasal syndrome, and 15 with unclassifiable dementia. Baseline clinical diagnoses were independently established without access to PET imaging results. Apolipoprotein E (ApoE) genotype analysis was performed on CI patients and 231 sex- and age-matched controls. Results: Of the 1,193 CI patients, 860 (72.1%) were amyloid-positive. The prevalence of amyloid positivity in AD and MCI patients was 86.8% (833/960) and 9.7% (14/144), respectively. In FTD patients, the prevalence of β-amyloid deposits was 5.6% (2/36). In the 4 corticobasal syndrome patients, 2 were amyloid-positive. Three of the 5 patients with dementia with Lewy bodies showed amyloid positivity, as did 6 of the 29 vascular dementia (20.7%) patients. The ApoEε4 allele frequency was significantly increased in amyloid-positive CI patients (30.5%) as compared with other amyloid-negative CI patients (14%) or controls (7.3%). Conclusion: Amyloid imaging may potentially be the most helpful parameter for differential diagnosis in dementia, particularly to distinguish between AD and FTD. Amyloid PET can be used in conjunction with the ApoEε4 allele genetic risk test for amyloid deposits.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2967/jnumed.119.240325

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 30

Metadata

Authors
Shi, Z., Fu, L.-P., Zhang, N., Zhao, X., Liu, S., Zuo, C., Cai, L., Wang, Y., Gao, S., Ai, L., Guan, Y.-H., Xu, B., & Ji, Y.
Venue
Journal of Nuclear Medicine
Published
2020-05-08
Volume
61
Issue
12
Pages
1814-1819
ISSN
  • 0161-5505 (ISSN-L)
  • 2159-662X
OpenAlex
W3021998742
Cited by
30
References
10
FWCI
3.19
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amyloid PET in Dementia Syndromes: A Chinese Multicenter Study. https://app.cochat.ai/papers/10.2967/jnumed.119.240325
The paper
Shi, Z., Fu, L.-P., Zhang, N., Zhao, X., Liu, S., Zuo, C., Cai, L., Wang, Y., Gao, S., Ai, L., Guan, Y.-H., Xu, B., & Ji, Y. (2020). Amyloid PET in Dementia Syndromes: A Chinese Multicenter Study. Journal of Nuclear Medicine. https://doi.org/10.2967/jnumed.119.240325

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.